from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0391/metZ

LFCtreatmentdescriptionclass of inhibitor

-0.385

Amikacinug/mL Amikacintranslation

-0.901

Cap5-10ug/mL Capreomycintranslation

-0.788

Rox10-50 ug/mL Roxithromycintranslation

1.191

SM2-5 ug/mL Streptomycintranslation

-1.022

Tet5-10 ug/mL Tetracyclinetranslation

-0.831

Rif0.2-5ug/mL Rifampicintranscription

0.136

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.108

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.728

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.198

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.434

Clofazimine10-13 ug/mL Clofaziminerespiration

0.260

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.994

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.535

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.042

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.207

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.500

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.047

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.493

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.745

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.686

KCN5-20 ug/mL Potassium cyaniderespiration

0.495

NaN30.2-2 mM Sodium aziderespiration

0.543

Nigericin50 uM Nigericinrespiration

-0.608

TRC10-150 ug/mL Triclosanrespiration

-1.249

TRZ10-25 ug/mL Thioridazinerespiration

-1.220

Valinomycin0.5-10 uM Valinomycinrespiration

0.012

ZnSO42 mM ZnSO4respiration

0.446

menadione6-10 ug/mL Menadionerespiration

-0.165

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.223

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.349

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.564

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.145

NRP_1Non-replicating persistence stage 1dosRassociated

0.485

Amp0.2mg/mL AmpicillincellWall

0.152

Cephalexin20-100 ug/mL CephalexincellWall

0.280

Cerulenin0.32-5 ug/mL CerulenincellWall

0.589

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.255

EMB10-20 ug/mL EthambutolcellWall

0.415

Eta12-40 ug/mL EthionamidecellWall

0.772

INH0.2-0.4 ug/mL IsoniazidcellWall

0.340

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.115

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.324

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.244

BZA0.12 mg/mL BenzamidearomaticAmides

-0.514

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.507

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.101

H2O24 mM hydrogen peroxideDNAdamaging

-0.041

Levo10 ug/mL LevofloxacinDNAdamaging

0.338

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.208

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.149

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.337

UVUV-irradiationDNAdamaging

-1.071

ARP41-4 ug/mL Antitubercular compound ARP4?

0.138

Antimycin12.5-50 ug/mL Antimycin A?

0.021

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.340

PA_110-50 ug/mL Antitubercular compound PA-1?

0.029

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.059

PA8240.2-2 ug/mL PA-824?

0.141

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.239

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.330

Verapamil50 uM Verapamil?

-0.300

mercaptoethanol2 mM 2-Mercaptoethanol?

0.557

methoxatin10-20 ug/mL Methoxatin?